All In Biotech

Drug Trial Radar · NCT00306787

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

A Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Patient-initiated Famciclovir 1000 mg b.i.d. x 1 Day to Valacyclovir 500 mg b.i.d. x 3 Days in Immunocompetent Adults With Recurrent Genital Herpes

Last checked: Nov 19, 2026Latest source record: Jun 30, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,179 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,179

Actual

Start

Mar 2006

Primary completion

Feb 2008

Study completion Feb 2008

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Mar 24, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the safety and efficacy of one-day famciclovir (1000 mg twice a day (b.i.d)) in reducing the duration of genital herpes lesions and the associated symptoms compared to three-day treatment with valacyclovir (500 mg capsule b.i.d).

Conditions

  • Genital Herpes

Interventions

  • FamciclovirDrug

    Famciclovir 500 mg tablet

  • ValacyclovirDrug

    Valacyclovir 500 mg capsule

  • Placebo matching famciclovirDrug

    Famciclovir placebo, matching in size, color and forms of famciclovir tablet.

  • Placebo matching valacyclovirDrug

    Valacyclovir placebo, matching in size, color and forms of valacyclovir capsule.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator-assessed Time to Healing of All Non-aborted Genital Herpes LesionsTime frame: 72 hours after initiation of study medication up to Day 20

Locations

66 sites in 4 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Novartis Investigative Site

    Chandler, Arizona

  • Women's Health Research

    Phoenix, Arizona

  • Quality of Life Medical & Research Center, LLC

    Tucson, Arizona

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • NEA Women's Clinic

    Jonesboro, Arkansas

  • The Woman's Clinic

    Little Rock, Arkansas

  • Providence Clinical Research

    Burbank, California

  • Dermatology Research Associates

    Los Angeles, California

  • Sacramento Research Medical Group

    Sacramento, California

  • North California Research Corp.

    Sacramento, California

  • Medical Center for Clinical Research

    San Diego, California

  • Conant Research

    San Francisco, California

  • Barbara Davis Center

    Denver, Colorado

  • Cohen & Womack, P.C.

    Lakewood, Colorado

  • Visions Clinical Research

    Boynton Beach, Florida

  • Women's Medical Research Group, LLC

    Clearwater, Florida

  • International Research Association LLC

    Miami, Florida

  • Orlando Clinical Research Ctr.

    Orlando, Florida

  • Avancia Research

    Pembroke Pines, Florida

  • University Clinical Research, Inc.

    Pembroke Pines, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • Mount Vernon Clinical Research

    Atlanta, Georgia

  • Medisphere Medical Research Center, LLC.

    Evansville, Indiana

  • Indiana University Infectious Disease Research Group

    Indianapolis, Indiana

  • Heartland Research Associates, LLC

    Wichita, Kansas

  • Common Wealth Biomedical Research

    Madisonville, Kentucky

  • SNBL Clinical Pharmacology Center

    Baltimore, Maryland

  • Future Care Studies

    Springfield, Massachusetts

  • Clayton Research Institute

    St Louis, Missouri

  • Deaconess Billings Clinic Research Center

    Billings, Montana

  • Heartland Clinical Research, Inc.

    Omaha, Nebraska

  • UNC Clinical Research.

    Raleigh, North Carolina

  • Hawthorne Medical Research, Inc.

    Winston-Salem, North Carolina

  • Providence Health Partners-Center for Clinical Research

    Dayton, Ohio

  • Lynne Health Science Institute

    Oklahoma City, Oklahoma

  • Westover Heights Clinic

    Portland, Oregon

  • Paddington Testing Co. Inc

    Philadelphia, Pennsylvania

  • Magee Womens Hospital

    Pittsburgh, Pennsylvania

  • S. Carolina Clinical Research Center

    Columbia, South Carolina

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.